Mantle Cell Lymphoma — Trials

Mantle Cell Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

706 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 180
Recruiting: 93
Ph III recruiting: 6
Growth YoY: —
Industry share: 26%
Top sponsor: City of Hope Medical Center
Termination share: 35.6%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (121)

clinicaltrialsPublishedShowing 51–52 of 52 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00843050	A Phase II Study to Evaluate Efficacy and Safety of P276-00 in Relapsed and/or Refractory Mantle Cell Lymphoma	terminated	Phase 2	13	Piramal Enterprises LimitedINDUSTRY	2	Jul 27, 2012	clinicaltrials
NCT00275262	A Study to Evaluate the Ability of Lupron Depot to Enhance Immune Function Following Bone Marrow Transplantation	terminated	Phase 2	25	AbbottINDUSTRY	1	May 6, 2010	clinicaltrials